IL45912A - Method and compositions containing glycine glucose electrolytes and mineral salts for treating scours - Google Patents
Method and compositions containing glycine glucose electrolytes and mineral salts for treating scoursInfo
- Publication number
- IL45912A IL45912A IL45912A IL4591274A IL45912A IL 45912 A IL45912 A IL 45912A IL 45912 A IL45912 A IL 45912A IL 4591274 A IL4591274 A IL 4591274A IL 45912 A IL45912 A IL 45912A
- Authority
- IL
- Israel
- Prior art keywords
- scours
- weight
- composition
- none
- glucose
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 15
- 239000004471 Glycine Substances 0.000 title abstract description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 15
- 239000008103 glucose Substances 0.000 title abstract description 14
- 150000003839 salts Chemical class 0.000 title abstract description 7
- 239000003792 electrolyte Substances 0.000 title description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 title description 5
- 239000011707 mineral Substances 0.000 title description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 15
- 208000003217 Tetany Diseases 0.000 claims abstract description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 16
- 229960001031 glucose Drugs 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000004227 calcium gluconate Substances 0.000 claims description 8
- 235000013927 calcium gluconate Nutrition 0.000 claims description 8
- 229960004494 calcium gluconate Drugs 0.000 claims description 8
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 8
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 8
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 6
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 6
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 1
- 239000000310 rehydration solution Substances 0.000 claims 1
- 244000309466 calf Species 0.000 abstract description 29
- 239000007864 aqueous solution Substances 0.000 abstract description 10
- 241000124008 Mammalia Species 0.000 abstract description 7
- 238000009472 formulation Methods 0.000 description 23
- 229940088710 antibiotic agent Drugs 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 238000002845 discoloration Methods 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 5
- 229910001415 sodium ion Inorganic materials 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- FGCSIJPPCNCQJB-FAOVPRGRSA-M sodium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;chloride Chemical compound [Na+].[Cl-].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O FGCSIJPPCNCQJB-FAOVPRGRSA-M 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 206010061291 Mineral deficiency Diseases 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- -1 for example Substances 0.000 description 3
- 229960001907 nitrofurazone Drugs 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000003022 colostrum Anatomy 0.000 description 2
- 235000021277 colostrum Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000009991 scouring Methods 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000029422 Hypernatremia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960003375 aminomethylbenzoic acid Drugs 0.000 description 1
- QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229940046545 animal allergen extract Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229940021013 electrolyte solution Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003630 glycyl group Chemical class [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004140 ketosis Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/807—Poultry or ruminant feed
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US421360A US3898328A (en) | 1973-12-03 | 1973-12-03 | Dry stable composition for the treatment of scours and dehydration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL45912A0 IL45912A0 (en) | 1974-12-31 |
| IL45912A true IL45912A (en) | 1977-10-31 |
Family
ID=23670187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL45912A IL45912A (en) | 1973-12-03 | 1974-10-23 | Method and compositions containing glycine glucose electrolytes and mineral salts for treating scours |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3898328A (de) |
| JP (1) | JPS5088212A (de) |
| AT (1) | AT338034B (de) |
| BE (1) | BE822770A (de) |
| BR (1) | BR7410073A (de) |
| CA (1) | CA1039192A (de) |
| DE (1) | DE2455281C3 (de) |
| DK (1) | DK599574A (de) |
| ES (1) | ES432307A1 (de) |
| FR (1) | FR2252848B1 (de) |
| GB (1) | GB1465308A (de) |
| IE (1) | IE41828B1 (de) |
| IL (1) | IL45912A (de) |
| NL (1) | NL179188C (de) |
| ZA (1) | ZA747054B (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ183492A (en) * | 1976-03-27 | 1980-04-28 | Beecham Group Ltd | Veterinary rehydration compositions containing monosaccharide amino acid and citric acid or citrate |
| US4202887A (en) * | 1977-06-27 | 1980-05-13 | Redel, Inc. | Livestock feed supplement |
| FR2467599B1 (fr) * | 1979-10-24 | 1983-07-29 | Agronomique Inst Nat Rech | Nouvelles compositions rehydratantes utiles notamment dans le traitement de la diarrhee chez le veau |
| EP0059057A1 (de) * | 1981-02-20 | 1982-09-01 | Beecham Group Plc | Behandlung der Diarrhee |
| FR2539006A1 (fr) * | 1983-01-12 | 1984-07-13 | Agronomique Inst Nat Rech | Composition rehydratante utilisable notamment dans l'alimentation de jeunes animaux ne pouvant plus digerer normalement le lait et complement pour sa preparation |
| EP0114104B1 (de) * | 1983-01-13 | 1989-04-19 | Colorado State University Research Foundation | Energiereiche Zusammensetzung zur mündlichen Verabreichung und Lösung zur Bekämpfung der Diarrhöe bei Säugetieren |
| DK454683D0 (da) * | 1983-10-03 | 1983-10-03 | Mogens Gjerloev | Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf |
| US5038396A (en) * | 1983-10-03 | 1991-08-06 | Mogens Gjerlov | Preparation for rehydrating monogastric animals, including new-born calves, pigs and human beings suffering from diarrhoea and use thereof |
| AU571011B2 (en) * | 1983-10-07 | 1988-03-31 | State Of Victoria, The | Treatment of neonatal calf diarrhoea |
| JPS6140754A (ja) * | 1984-07-31 | 1986-02-27 | Meiji Seika Kaisha Ltd | イヌロオリゴ糖含有飼料ならびにこれを用いて家畜を飼育する方法 |
| US4839347A (en) * | 1984-11-29 | 1989-06-13 | Techmix, Inc. | Composition for treating dehydration |
| FR2574295B1 (fr) * | 1984-12-07 | 1988-02-26 | Rech Etu Therapeutiques | Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies |
| GB8528307D0 (en) * | 1985-11-18 | 1985-12-24 | Beecham Group Plc | Veterinary compositions |
| ES2038122T3 (es) * | 1985-11-18 | 1993-07-16 | Beecham Group Plc | Un procedimiento para la preparacion de una composicion veterinaria2. |
| NL8601806A (nl) * | 1986-07-10 | 1988-02-01 | Weiproduktenfabriek Borculo W | Werkwijze voor het bevorderen van de gezondheid en de groei van biggen. |
| US5962733A (en) * | 1996-09-25 | 1999-10-05 | Vets Plus, Inc. | Glutamine containing electrolyte solution for calf scours |
| US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| US6066341A (en) * | 1999-03-15 | 2000-05-23 | Farnam Companies, Inc. | Composition for the treatment of scours in calves |
| US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
| DK175877B1 (da) * | 2002-11-11 | 2005-05-09 | Pharmalett As | Præparater til anvendelse som terapeutisk middel |
| US7181987B2 (en) * | 2003-05-02 | 2007-02-27 | Peter Winston Hamady | Precessional device and method |
| US7850989B2 (en) * | 2003-06-12 | 2010-12-14 | Provimi North America, Inc. | Critical care for neonatal calves |
| US7527816B2 (en) * | 2004-08-06 | 2009-05-05 | Techmix, Inc. | Feed supplement and method |
| WO2007065172A1 (en) | 2005-12-02 | 2007-06-07 | Hill's Pet Nutrition, Inc. | Methods for altering stool quality and/or stool frequency |
| US20090136588A1 (en) * | 2005-12-02 | 2009-05-28 | Hill's Pet Nutrition, Inc. | Methods For Altering Food Intake, Modifying Nutrient Digestibility and Altering Stool Quality and/or Stool Frequency |
| US20070160683A1 (en) * | 2006-01-12 | 2007-07-12 | Land O'lakes Purina Feed Llc | Electrolyte supplement and method of use |
| EP1864692A1 (de) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Verwendung von peptiden zum Schutz von Strahlenschäden |
| US8529965B2 (en) * | 2007-07-09 | 2013-09-10 | Hill's Pet Nutrition, Inc. | Compositions and methods for altering stool quality in an animal |
| DK2178391T3 (da) * | 2007-07-09 | 2014-08-25 | Hills Pet Nutrition Inc | Sammensætninger og fremgangsmåder til at ændre afføringskvaliteten hos et dyr |
| RU2444907C2 (ru) * | 2007-07-09 | 2012-03-20 | Хилл'С Пет Ньютришн, Инк. | Композиция корма, набор и способ изменения качества стула у животного (варианты) |
| EP2386649A1 (de) | 2010-05-12 | 2011-11-16 | Tiense Suikerraffinaderij N.V. | Verfahren zur Gewinnung von Betain aus Melasse |
| US9283250B2 (en) * | 2013-03-14 | 2016-03-15 | Ag Odor Control, LLC | Oral administration of electrolyzed water for treatment and prevention of PEDv in swine, swine herds and swine confinements |
| US11285122B2 (en) | 2013-07-02 | 2022-03-29 | Ecoplanet Environmental Llc | Volatile organic compound formulations having antimicrobial activity |
| AU2014284267B2 (en) * | 2013-07-02 | 2018-05-10 | Ecoplanet Environmental Llc | Volatile organic compound formulations having antimicrobial activity |
| CN106455629A (zh) * | 2014-06-26 | 2017-02-22 | 蒂西苏克拉菲纳德里有限公司 | 甜菜碱组合物、葡萄糖组合物及其用途 |
| US12097173B2 (en) | 2019-09-27 | 2024-09-24 | Ecoplanet Environmental Llc | Volatile organic compound formulations having antimicrobial activity |
-
1973
- 1973-12-03 US US421360A patent/US3898328A/en not_active Expired - Lifetime
-
1974
- 1974-10-23 IL IL45912A patent/IL45912A/en unknown
- 1974-10-28 CA CA212,461A patent/CA1039192A/en not_active Expired
- 1974-11-01 ZA ZA00747054A patent/ZA747054B/xx unknown
- 1974-11-06 GB GB4803674A patent/GB1465308A/en not_active Expired
- 1974-11-07 FR FR7436997A patent/FR2252848B1/fr not_active Expired
- 1974-11-11 IE IE2316/74A patent/IE41828B1/en unknown
- 1974-11-18 DK DK599574A patent/DK599574A/da unknown
- 1974-11-22 DE DE2455281A patent/DE2455281C3/de not_active Expired
- 1974-11-26 ES ES432307A patent/ES432307A1/es not_active Expired
- 1974-11-27 NL NLAANVRAGE7415477,A patent/NL179188C/xx not_active IP Right Cessation
- 1974-11-28 AT AT954474A patent/AT338034B/de not_active IP Right Cessation
- 1974-11-29 BE BE151000A patent/BE822770A/xx not_active IP Right Cessation
- 1974-12-02 JP JP49138311A patent/JPS5088212A/ja active Pending
- 1974-12-02 BR BR10073/74A patent/BR7410073A/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3898328A (en) | 1975-08-05 |
| DK599574A (de) | 1975-07-28 |
| ZA747054B (en) | 1976-06-30 |
| NL7415477A (nl) | 1975-06-05 |
| DE2455281B2 (de) | 1979-08-09 |
| ES432307A1 (es) | 1977-04-01 |
| GB1465308A (en) | 1977-02-23 |
| IE41828L (en) | 1975-06-03 |
| NL179188C (nl) | 1986-08-01 |
| IL45912A0 (en) | 1974-12-31 |
| BR7410073A (pt) | 1976-06-08 |
| IE41828B1 (en) | 1980-04-09 |
| CA1039192A (en) | 1978-09-26 |
| DE2455281C3 (de) | 1980-05-22 |
| AT338034B (de) | 1977-07-25 |
| ATA954474A (de) | 1976-11-15 |
| DE2455281A1 (de) | 1975-06-05 |
| FR2252848A1 (de) | 1975-06-27 |
| FR2252848B1 (de) | 1977-11-04 |
| BE822770A (fr) | 1975-05-29 |
| NL179188B (nl) | 1986-03-03 |
| JPS5088212A (de) | 1975-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL45912A (en) | Method and compositions containing glycine glucose electrolytes and mineral salts for treating scours | |
| EP0226332B1 (de) | Veterinäre Zusammensetzungen | |
| EP0011489B1 (de) | Ein schmerzstillendes Brausepulver und Verfahren zu seiner Herstellung | |
| US5914346A (en) | Methods of treating animals to enhance natural killer lymphocyte function | |
| IL93284A (en) | A vibrant product for the preparation of an oral solution for rehydration | |
| US4931290A (en) | Milk fever prophylactic treatment and composition | |
| BG66212B1 (bg) | Форма за приложение | |
| US2607716A (en) | Prophylactic compositon for scours | |
| US3065133A (en) | Imidazoles for the control of histomoniasis | |
| US4076803A (en) | Synergistic combination of metal proteinates with beta-chlorovinyl dialkyl phosphates | |
| EP0393909A1 (de) | Zusammensetzung | |
| US2893914A (en) | Thiadicarbocyanine anthelmintic compositions and methods of using them | |
| US3155587A (en) | Stable liquid preparations of 7-chlorotetracycline | |
| CA2126519A1 (en) | Nutritional supplement for calving ruminant animals | |
| CA1143658A (en) | Skeletal muscle relaxant | |
| US2899356A (en) | Cyanacethydrazide compositions for | |
| RU2145499C1 (ru) | Препарат для лечения и профилактики желудочно-кишечных и респираторных заболеваний новорожденных телят и ягнят - гастропульмин | |
| US3714361A (en) | Certain hydroxamic acids as growth promoting agents | |
| SU1757673A1 (ru) | Антикетозна добавка дл коров | |
| US3038806A (en) | Growth accelerating compositions | |
| RU2060729C1 (ru) | Способ получения пероральной лекарственной формы цитокина (его варианты) | |
| US4124626A (en) | Control of swine dysentery with AV290 and salts or complexes thereof | |
| RU1808323C (ru) | "Профилактическое средство "Терокс" дл новорожденных тел т" | |
| US3224939A (en) | Method for treating helminthic infections | |
| EP0112061A2 (de) | Pharmazeutische und tierärztliche Guanoxabenz enthaltende Zusammensetzung |